Rachel M Hughes

ORCID: 0000-0002-0184-8666
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Neuroscience and Neuropharmacology Research
  • Fungal Infections and Studies
  • Parkinson's Disease Mechanisms and Treatments
  • Antifungal resistance and susceptibility
  • Cellular transport and secretion
  • Neurogenetic and Muscular Disorders Research
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Alzheimer's disease research and treatments
  • Autophagy in Disease and Therapy
  • Neurotransmitter Receptor Influence on Behavior
  • Biomedical Ethics and Regulation
  • Lysosomal Storage Disorders Research
  • Mitochondrial Function and Pathology
  • Genetic Neurodegenerative Diseases
  • Amyotrophic Lateral Sclerosis Research
  • Receptor Mechanisms and Signaling
  • Neutropenia and Cancer Infections

University of Sheffield
2019-2024

Memorial Sloan Kettering Cancer Center
2017-2020

The Ohio State University
2007-2008

It is important to understand how the disease process affects metabolic pathways in amyotrophic lateral sclerosis and whether these can be manipulated ameliorate progression. To analyse basis of defect we used a phenotypic profiling approach. Using fibroblasts reprogrammed induced astrocytes from C9orf72 sporadic cases measured production rate reduced nicotinamide adenine dinucleotides (NADH) 91 potential energy substrates simultaneously. Our screening approach identified that have distinct...

10.1093/brain/awz302 article EN cc-by Brain 2019-09-08

We sought to describe the clinical experience of voriconazole as primary antifungal prophylaxis (AFP) in allogeneic hematopoietic cell transplant recipients (allo-HCTr). This was a single-center retrospective study adult allo-HCTr (1 January 2014 31 December 2016) who received ≥two doses voriconazole-AFP. Voriconazole-AFP started on day +7 post-HCT and continued at least through +60 post-HCT, or longer clinically indicated. reviewed rate, reasons, risk factors voriconazole-AFP...

10.1093/mmy/myaa008 article EN Medical Mycology 2020-03-06

Abstract Results from several experiments monitoring extracellular dopamine (DA) after stimulating axons at high frequencies have been interpreted as evidence for release two populations of vesicles in dopaminergic varicosities. In addition, these suggested that cocaine and other transporter (DAT) inhibitors promote transfer or itself a reserve pool to readily available pool. We developed computer model simulation with the goal determining set mathematical formulas describe movement between...

10.1002/syn.20572 article EN Synapse 2008-09-15

Abstract Background High rates of discontinuation voriconazole (VCZ) antifungal prophylaxis (AFP) due to toxicities have been reported from single centers in allogeneic hematopoietic (allo-HCT) recipients. We sought describe (i) adherence AFP guidelines and (ii) reasons for premature VCZ (D/C). Methods Retrospective review 215 adult allo-HCT recipients September 1, 2014–December 31, 2015 at our center. Per standards care (SOC), patients received micafungin Day 2 post-allo-HCT, then switched...

10.1093/ofid/ofx163.014 article EN cc-by-nc-nd Open Forum Infectious Diseases 2017-01-01

Results from several different experimental paradigms have been interpreted as supporting the concept that two populations of dopamine storage vesicles exist in nerve terminals dopaminergic neurons. The goal this work is to develop a computer simulation model varicosity provides plausible quantitative description these and possible set rules for movement between vesicles. We first looked at how well one compartment accurate simulations published data. allocates among three compartments:...

10.1186/1471-2202-8-s2-p112 article EN cc-by BMC Neuroscience 2007-07-01
Coming Soon ...